CHARLES KIM v. SYK BIOSCIENCES LLC & Others.

Massachusetts Appeals Court·Decided April 15, 2026·No. 25-P-0616·Unpublished

Opinion

NOTICE: Summary decisions issued by the Appeals Court pursuant to M.A.C. Rule 23.0, as appearing in 97 Mass. App. Ct. 1017 (2020) (formerly known as rule 1:28, as amended by 73 Mass. App. Ct. 1001 [2009]), are primarily directed to the parties and, therefore, may not fully address the facts of the case or the panel's decisional rationale. Moreover, such decisions are not circulated to the entire court and, therefore, represent only the views of the panel that decided the case. A summary decision pursuant to rule 23.0 or rule 1:28 issued after February 25, 2008, may be cited for its persuasive value but, because of the limitations noted above, not as binding precedent. See Chace v. Curran, 71 Mass. App. Ct. 258, 260 n.4 (2008).

COMMONWEALTH OF MASSACHUSETTS

APPEALS COURT

25-P-616

CHARLES KIM

vs.

SYK BIOSCIENCES LLC & others.1

MEMORANDUM AND ORDER PURSUANT TO RULE 23.0

The plaintiff, Dr. Charles Kim, appeals from a Superior

Court judgment dismissing his eight-count complaint on the

ground that the forum selection clauses (FSCs) in his employment

agreements with the defendants SYK Biosciences LLC (SYK) and

Pulsethera, Inc. (P-Inc.) require the case to be filed in

Delaware. On appeal, Kim argues that the FSCs do not apply to

all of his claims or to those defendants who are not parties to

his agreements with SYK and P-Inc. We vacate so much of the

judgment as dismissed Kim's Massachusetts statutory claims, but

we otherwise affirm the judgment.

Background. We recite certain essential facts as alleged in Kim's verified first amended complaint (the operative complaint). Kim is a chemist and scientist living in Boston. The defendant SYK was a startup biotechnology company that operated in Boston until its dissolution in 2023, and the defendants Leon F. Hebert, Jr., and Michael Mansour are Massachusetts residents who are principals of SYK and who exercised significant managerial control over SYK at all relevant times. The defendants P-Inc. and Pulsethera Corp. (P- Corp.) are startup medical device companies based in Boston. The defendants Ji-Xin Cheng and Steven Qian are Massachusetts residents who, along with Hebert and Mansour, are principals of P-Corp. and exercised significant managerial control over P- Corp. at all relevant times. The complaint often refers to P- Inc. and P-Corp. collectively and interchangeably as "Pulsethera," and we do the same, except where necessary to distinguish one from the other.

1. SYK agreement. On December 8, 2021, Kim signed a "consulting agreement" with SYK to work as a scientist. The SYK agreement was for a term of twelve months, "unless there is an earlier termination or extension as provided herein," but it did not include any further provision regarding extensions. The SYK agreement provided for payment to Kim at a rate of $200 per hour

plus expenses, contained an acknowledgment that he was an independent contractor, and included a Delaware choice of law clause and an FSC providing that "any dispute under this [a]greement that cannot be settled by the [p]arties shall be decided in the [F]ederal or a [S]tate court of the State of Delaware."

In November 2022, Kim reminded Hebert that the SYK agreement would be expiring soon and requested an extension. Hebert stated that he would send paperwork to extend the agreement, but he did not do so. Kim alleges that the SYK agreement expired on December 8, 2022. Later that December, Kim again asked Hebert to extend the SYK agreement, and to backdate the extension to account for work Kim had done since the expiration. Once again, Hebert did not do so, and so in February 2023, Kim asked Hebert and Mansour to "sign a follow-on contract for SYK that covers work from December 9, 2022 and onward. This would cover the work we've been doing to prepare formulations for the baboon studies." Once again, no extension paperwork was sent. At least as to the work he performed in December 2022, Kim alleges that he made the "reasonable assumption that his work for the [d]efendant companies would be paid at the rate of $200 per hour, as provided by, inter alia, the [a]greements." Further, SYK, Hebert, and Mansour knew that

Kim continued to perform work for SYK following the agreement's expiration date.

SYK did not pay Kim for the work he did between November 2022 and February 2023 -- including thirty-seven hours before the asserted expiration date and fifty-nine and one-half hours after that date -- and did not reimburse him for a software expense he incurred after the expiration date. In an exchange of electronic mail messages in February and March 2023, Hebert acknowledged the delay in paying Kim "the amount due," and stated that he (Hebert) would speak or had spoken to his investor in an effort to obtain payment to Kim, but the payments were never made.

2. P-Inc. agreement. In the meantime, on September 23, 2022, after discussions with Hebert and Mansour, Kim had signed an agreement with P-Inc. to work as a scientist, on terms essentially identical to those in the SYK agreement. The P-Inc. agreement also included a choice of law clause and an FSC identical to those in the SYK agreement. Despite P-Inc.'s being the agreement's signatory, Kim alleges that he was working for both P-Inc. and P-Corp. -- i.e., that they were his "joint employers" -- because the sole payment he received from either entity was from P-Corp. He asserts that the two entities were indifferent to maintaining any material distinction between

themselves. Kim received no payment for the work he performed for Pulsethera from December 7-31, 2022.

3. The claims. The operative complaint asserted eight claims, four of which were asserted against all defendants. Count one claimed that Kim was an employee but was misclassified as an independent contractor in violation of G. L. c. 149, § 148B. Count two claimed violations of the Wage Act, G. L. c. 149, § 148. Count three asserted a quantum meruit claim and count four asserted an unjust enrichment claim; both counts focused on the defendants' failure to pay Kim for the work he performed.

Of the remaining claims, count five asserted that Pulsethera, Hebert, and Mansour, despite never intending to pay Kim for work he would do for Pulsethera, fraudulently induced Kim to enter the P-Inc. agreement and to perform such work. Count six asserted that SYK, Pulsethera, Hebert, and Mansour, while both agreements were in effect, made false and misleading statements to Kim regarding their intention to pay him for the work he was doing for SYK and Pulsethera. Count seven asserted a promissory estoppel claim against SYK, Pulsethera, Hebert, and Mansour, alleging that Kim performed work for them in reasonable reliance on their promises to pay him. Finally, count eight asserted a conspiracy claim against all defendants, alleging an

unlawful combination to (among other things) obtain Kim's work without paying him. Notably, Kim did not assert any breach of contract claims.2 On the defendants' motion to dismiss under Mass. R. Civ. P.

12 (b) (6), 365 Mass. 754 (1974), based on the Delaware forum selection clauses in the SYK and P-Inc. agreements, a judge dismissed all claims against all defendants. Kim now appeals.

Discussion. In an appeal of a judgment dismissing a complaint based on an FSC, "we take the facts alleged in the complaint to be true and draw all reasonable inferences favorable to the plaintiff." Boland v. George S. May Int'l Co., 81 Mass. App. Ct. 817, 818 n.4 (2012). We review the dismissal de novo. See Casavant v. Norwegian Cruise Line, Ltd., 63 Mass. App. Ct. 785, 792-793 (2005), cert. denied, 546 U.S. 1173 (2006). This case turns largely on the interpretation of the FSCs. Under the agreements' Delaware choice of law clauses, Delaware law generally controls the interpretation of the FSCs. See Jacobson v. Mailboxes Etc. U.S.A., Inc., 419 Mass. 572, 575

Free access — add to your briefcase to read the full text and ask questions with AI

CHARLES KIM v. SYK BIOSCIENCES LLC & Others., (Mass. Ct. App. 2026).

CHARLES KIM v. SYK BIOSCIENCES LLC & Others. (CHARLES KIM v. SYK BIOSCIENCES LLC & Others.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Ashall Homes Ltd. v. ROK Entertainment Group Inc.
992 A.2d 1239 (Court of Chancery of Delaware, 2010)
Adoption of Mary
610 N.E.2d 898 (Massachusetts Supreme Judicial Court, 1993)
Ingres Corp. v. CA, INC.
8 A.3d 1143 (Supreme Court of Delaware, 2010)
Machado v. System4 LLC
471 Mass. 204 (Massachusetts Supreme Judicial Court, 2015)
National Industries Group v. Carlyle Investment Management L.L.C.
67 A.3d 373 (Supreme Court of Delaware, 2013)
Gabbidon v. King
414 Mass. 685 (Massachusetts Supreme Judicial Court, 1993)
Jacobson v. Mailboxes Etc. U.S.A., Inc.
419 Mass. 572 (Massachusetts Supreme Judicial Court, 1995)
Carey v. New England Organ Bank
446 Mass. 270 (Massachusetts Supreme Judicial Court, 2006)
Bay State Gas Co. v. Department of Public Utilities
947 N.E.2d 1077 (Massachusetts Supreme Judicial Court, 2011)
Melia v. Zenhire, Inc.
967 N.E.2d 580 (Massachusetts Supreme Judicial Court, 2012)
Casavant v. Norwegian Cruise Line, Ltd.
829 N.E.2d 1171 (Massachusetts Appeals Court, 2005)
Chace v. Curran
881 N.E.2d 792 (Massachusetts Appeals Court, 2008)
Baby Furniture Warehouse Store, Inc. v. Meubles D&F Ltée
911 N.E.2d 800 (Massachusetts Appeals Court, 2009)
Dixon v. Perry & Slesnick, P.C.
914 N.E.2d 97 (Massachusetts Appeals Court, 2009)
Boland v. George S. May International Co.
969 N.E.2d 166 (Massachusetts Appeals Court, 2012)
Ajemian v. Yahoo!, Inc.
987 N.E.2d 604 (Massachusetts Appeals Court, 2013)